Key facts for NCD 150.2
- Benefit category
- Durable Medical Equipment
- Effective date
- 04/27/2005
- Implemented 08/01/2005
- Transmittal
- Transmittal 41
- Versions published
- 2
TL;DR
NCD 150.2 sets Medicare's national policy for osteogenic stimulators under the benefit category "Durable Medical Equipment", effective 04/27/2005 and implemented 08/01/2005. The noninvasive stimulator device is covered only for the following indications: It has been revised 1 time since publication and binds every Medicare Administrative Contractor nationally.
Item or service described
Electrical Osteogenic Stimulators
A. General
Electrical stimulation to augment bone repair can be attained either invasively or non-invasively. Invasive devices provide electrical stimulation directly at the fracture site either through percutaneously placed cathodes or by implantation of a coiled cathode wire into the fracture site. The power pack for the latter device is implanted into soft tissue near the fracture site and subcutaneously connected to the cathode, creating a self-contained system with no external components. The power supply for the former device is externally placed and the leads connected to the inserted cathodes. With the non-invasive device, opposing pads, wired to an external power supply, are placed over the cast. An electromagnetic field is created between the pads at the fracture site.
Ultrasonic Osteogenic Stimulators
A. General
An ultrasonic osteogenic stimulator is a noninvasive device that emits low intensity, pulsed ultrasound. The device is applied to the surface of the skin at the fracture site and ultrasound waves are emitted via a conductive coupling gel to stimulate fracture healing. The ultrasonic osteogenic stimulators are not be used concurrently with other non-invasive osteogenic devices.
Indications and limitations of coverage
Electrical Osteogenic Stimulators
B. Nationally Covered Indications
• Noninvasive Stimulator
The noninvasive stimulator device is covered only for the following indications:
• Nonunion of long bone fractures;
• Failed fusion, where a minimum of 9 months has elapsed since the last surgery;
• Congenital pseudarthroses;
• Effective July 1, 1996, as an adjunct to spinal fusion surgery for patients at high risk of pseudarthrosis due to previously failed spinal fusion at the same site or for those undergoing multiple level fusion. A multiple level fusion involves 3 or more vertebrae (e.g., L3-L5, L4-S1, etc).
• Effective September 15, 1980, nonunion of long bone fractures is considered to exist only after 6 or more months have elapsed without healing of the fracture.
• Effective April 1, 2000, nonunion of long bone fractures is considered to exist only when serial radiographs have confirmed that fracture healing has ceased for 3 or more months prior to starting treatment with the electrical osteogenic stimulator. Serial radiographs must include a minimum of 2 sets of radiographs, each including multiple views of the fracture site, separated by a minimum of 90 days.
• Invasive (Implantable) Stimulator
The invasive stimulator device is covered only for the following indications:
• Nonunion of long bone fractures;
• Effective July 1, 1996, as an adjunct to spinal fusion surgery for patients at high risk of pseudarthrosis due to previously failed spinal fusion at the same site or for those undergoing multiple level fusion. A multiple level fusion involves 3 or more vertebrae (e.g., L3-L5, L4-S1, etc).
• Effective September 15, 1980, nonunion of long bone fractures is considered to exist only after 6 or more months have elapsed without healing of the fracture.
• Effective April 1, 2000, nonunion of long bone fractures is considered to exist only when serial radiographs have confirmed that fracture healing has ceased for 3 or more months prior to starting treatment with the electrical osteogenic stimulator. Serial radiographs must include a minimum of 2 sets of radiographs, each including multiple views of the fracture site, separated by a minimum of 90 days.
Ultrasonic Osteogenic Stimulators
B. Nationally Covered Indications
Effective January 1, 2001, ultrasonic osteogenic stimulators are covered as medically reasonable and necessary for the treatment of nonunion fractures. In demonstrating non-union fractures, CMS expects:
• A minimum of 2 sets of radiographs, obtained prior to starting treatment with the osteogenic stimulator, separated by a minimum of 90 days. Each radiograph set must include multiple views of the fracture site accompanied with a written interpretation by a physician stating that there has been no clinically significant evidence of fracture healing between the 2 sets of radiographs; and,
• Indications that the patient failed at least one surgical intervention for the treatment of the fracture.
• Effective April 27, 2005, upon reconsideration of ultrasound stimulation for nonunion fracture healing, CMS determines that the evidence is adequate to conclude that noninvasive ultrasound stimulation for the treatment of nonunion bone fractures prior to surgical intervention is reasonable and necessary. In demonstrating non-union fractures, CMS expects:
• A minimum of 2 sets of radiographs, obtained prior to starting treatment with the osteogenic stimulator, separated by a minimum of 90 days. Each radiograph set must include multiple views of the fracture site accompanied with a written interpretation by a physician stating that there has been no clinically significant evidence of fracture healing between the 2 sets of radiographs.
C. Nationally Non-Covered Indications
Nonunion fractures of the skull, vertebrae and those that are tumor-related are excluded from coverage.
Ultrasonic osteogenic stimulators may not be used concurrently with other non-invasive osteogenic devices.
Ultrasonic osteogenic stimulators for fresh fractures and delayed unions remains non-covered.
(This NCD last reviewed June 2005.)
Text reproduced from the CMS Medicare Coverage Database record for NCD 150.2 version 2. View the original on cms.gov.
Local policies that build on this NCD
1 active Local Coverage Determination cites NCD 150.2 among its related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.
- Osteogenesis Stimulators, LCD L33796 · CGS Administrators, LLC; Noridian Healthcare Solutions, LLC
How MACs bill NCD 150.2
A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 1 current article in the Medicare Coverage Database names NCD 150.2, from 2 contractors. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.
| Contractor | Articles |
|---|---|
| CGS Administrators, LLC | A52513 |
| Noridian Healthcare Solutions, LLC | A52513 |
A52513: Osteogenesis Stimulators - Policy Article
Article, effective 2026-05-18 · CGS Administrators, LLC (17013, 18003); Noridian Healthcare Solutions, LLC (16013, 19003) · CMS record
No covered diagnosis list. Local policy: L33796 Osteogenesis Stimulators.
Coverage analysis history
CMS opens a national coverage analysis (NCA) to create or reconsider an NCD; the analysis carries a CAG tracking number, the evidence review and the decision memo. The Medicare Coverage Database links 3 analyses to NCD 150.2, listed here in the order CMS opened them (by NCA record number). A reconsideration ("Recon") revisits an earlier decision; an analysis whose status is open is still in progress.
- CAG-00043N Electrical Stimulation for Fracture Healing (New, Closed)
- CAG-00022N Ultrasound Stimulation for Nonunion Fracture Healing (New, Closed)
- CAG-00022R Ultrasound Stimulation for Nonunion Fracture Healing (1st Recon, Closed)
Revision history
06/2005 - Determined evidence adequate to conclude that non-invasive ultrasound stimulation for treatment of nonunion bone fractures prior to surgical intervention is reasonable and necessary. Effective date 04/27/2005. Implementation date 08/01/2005. ( TN 41 ) (CR 3836)
11/2000 - Permited coverage for ultrasonic osteogenic stimulators when two sets of radiographs document nonunion of fracture, and patient has failed at least one surgical intervention for treatment of fracture. Effective and implementation dates 01/01/2001. ( TN 131 )
02/2000 - Defined nonunion of long bone fractures when fracture healing has ceased for 3 or more months as confirmed by serial radiographs. Effective and implementation dates 04/01/2000. ( TN 123 ) (CR 1085)
03/1997 - Denied coverage for osteogenic stimulators due to insufficient evidence to support medical necessity. Effective date 04/03/1997. (TN 92)
06/1996 - Expanded coverage to include use as an adjunct to spinal fusion surgery and provided clarification when noninvasive osteogenic stimulation is indicated after failed fusion. Effective date 07/01/1996. (TN 85)
How this NCD shows up on remittances
A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.
For teams evaluating QuickIntell software
Evaluate a coverage-review workflow around NCD 150.2
Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions — NCD 150.2
What does NCD 150.2 cover?
The noninvasive stimulator device is covered only for the following indications: The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.
When did NCD 150.2 take effect?
The current version (2) is effective 04/27/2005, implemented 08/01/2005, published in transmittal 41. CMS lists 2 versions of this NCD.
Does a Local Coverage Determination override NCD 150.2?
No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Coverage Database NCDs via the CMS Coverage APIVersion API snapshot 2026-09-27 · effective 2026-09-20 · file national-coverage-ncd.jsonSHA-256 a90fadfd264b9ef4…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
- Medicare Coverage Database national coverage analyses (NCA/CAL report) via the CMS Coverage APIVersion API snapshot 2026-11-16 · effective 2026-11-16 · file national-coverage-ncacal.jsonSHA-256 563369a07b95140a…
Disclaimer
This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.